Macrophage-tropic virus variants evolved during the course of infection of individual rhesus monkeys with cloned, non-macrophagetropic simian immunodeficiency virus. Specific changes in the envelope gene (env) were found to be primarily responsible for the dramatic increase in the ability of the virus to replicate in macrophages. Cloned viruses differing at nine amino acid positions in env exhibited a more than 100-fold difference in replicative capacity for primary cultures of rhesus monkey alveolar macrophages. At least five of the nine amino acid changes contributed to macrophage tropism. These determinants were distributed across the full length ofenv, including both the gpl20 and gp4l products of the env gene. Furthermore, the emergence of macrophagetropic variants in vivo was associated with specific pathologic manifestations in which the macrophage is the major infected cell type. Thus, major determinants of macrophage tropism reside in env, they can be complex in nature, and the presence of macrophage-tropic virus variants in vivo can influence the disease course and disease manifestations.
It is now well established that the human immunodeficiency virus (HIV) uses the CD4 antigen as its primary, initial receptor (18, 24, 23) and that the CD4+ lymphocyte is a major target of virus replication. The decline in CD4+ lymphocyte concentrations in HIV-infected people clearly contributes to the eventual development of AIDS. Less appreciated is the role of monocytes and macrophages. Numerous infected macrophages have been noted in tissues from humans that have died from HIV infection (8, 29) . In fact, the tissue macrophage may be the major cell type harboring HIV in most infected individuals (10, 21, 22) . Some HIV isolates in the laboratory replicate well in lymphoid and monocyte/macrophage cells, while others replicate well only in lymphoid cells (3, 11, 17) . Infection of monocytes/macrophages by HIV appears to be predominantly a CD4-mediated event (2, 28) . Monocyte/macrophage infection is a unifying feature of all lentiviruses, including the HIV-related lentiviruses of ungulates (visna virus, caprine arthritis-encephalitis virus, and equine infectious anemia virus) and monkeys (simian immunodeficiency virus [SIV]) (for review, see references 5, 7, and 26) . However, the importance of monocytes/macrophages for the evolution of the chronic disease caused by HIV has not been defined. Is infection of monocytes/macrophages essential for persistent infection by HIV? Does infection of monocytes/macrophages influence the disease course and/or disease manifestations? What are the mechanisms that allow some isolates to enter both lymphocytes and macrophages in a CD4-dependent fashion and others to infect lymphocytes only?
SIV exhibits extensive similarity to HIV in genomic organization, gene sequences, and biological properties (5, 9) . Molecularly cloned SIVmac239 causes AIDS and death in the common rhesus monkey (Macaca mulatta) (14) . About 40% of rhesus monkeys infected with this cloned virus die with AIDS within 6 months of infection. The other 60% develop a more protracted disease course that also * Corresponding author.
closely resembles AIDS in humans. Features of the AIDSlike disease include CD4 depletion, opportunistic infections, generalized lymphoid depletion, emaciation, and a unique encephalitis, all characteristic of HIV-1-induced disease in humans. The complete genetic sequence of the SIVmac239 clone has been determined (30) .
In this report, we define the major genetic determinants of macrophage tropism that reside in the env gene. Specific amino acid changes that increase virus replication in macrophages appear to influence the particular pathologic manifestations that are observed.
MATERIALS AND METHODS
Virus. SIVmac316 was originally isolated from culture supernatants of alveolar macrophages taken by bronchoalveolar lavage from rhesus monkey 316-85 at the time of death. Virus stock was prepared following short-term propagation of virus in alveolar macrophages. SIVmacl32 was isolated from the blood of rhesus monkey 132-87 near the time of death (6) . Virus production in the cell-free supernatant was monitored by assay of reverse transcriptase activity (4, 25) or assay of p279ag antigen with a commercial antigen capture kit (Coulter Co., Hialeah, Fla.).
Cells and alveolar macrophage culture. The human T-B hybrid cell line CEMx174 was maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum. Rhesus monkey peripheral blood lymphocytes (PBL) were obtained by banding over sodium diatrizoate-Ficoll (1.077 to 1.080 g/ml at 20°C; Organon Teknika Corp., Durham, N.C.). PBL were treated with 1 ,g of phytohemagglutinin per ml for 48 h, washed free of lectin, and maintained in RPMI 1640 containing 20% fetal calf serum, 10% interleukin-2 (Electro-Nucleonics, Inc., Fairfield, N.J.), 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml. Alveolar macrophages were obtained by bronchoalveolar lavage from healthy, mature rhesus macaques that were serologically negative for SIV, type D retrovirus, and simian foamy viruses. Ninety-five percent or more of the cells were demonstrated to be macrophages on the basis of morphologic criteria, adherence to plastic flasks, cell surface markers, and opsonizing activity, as described previously (6, 31) . Macrophages were maintained in RPMI 1640 medium supplemented with 20% HIV-negative human serum (GIBCO Laboratories, Grand Island, N.Y.), 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 0. 25 Site-directed mutagenesis was performed by overlap extension by PCR as described before (12, 19 (Fig. 2) . Oligonucleotides corresponding to the ends of the genome were also used, with an additional EcoRI recognition tag for cloning. Recombinants were then constructed by using the infectious SIVmac239 clone and fragments derived from the SIVmac316 genome (Fig. 2) .
Recombinant clones that contained the right long terminal repeat (LTR) with part of nef from SIVmac316 replicated well in the CEMx174 lymphoid cell line, but they did not demonstrate any significant macrophage tropism (Fig. 3A determinants of macrophage tropism in this system. The macrophage-tropic 239/316ENV recombinant and the parental SIVmac239 cloned virus replicated with similar kinetics and to similar extents in rhesus monkey PBL cultures (Fig.  3C ). Cloned and uncloned SIVmac316 also replicated similarly to SIVmac239 in CEMx174 cells (data not shown).
A BanI restriction site at nt 8158 was used to make further recombinants to gauge the relative contribution of sequences to the left and right of this site. A recombinant containing SIVmac316 sequences from nt 8158 to 9230 (239/316TM) replicated significantly better than the parental SIVmac239 in the primary macrophage cultures (Fig. 3B) . This indicates that sequence changes in the TM region of the env gene alone can impart increased ability to replicate in macrophage cultures. A recombinant containing SIVmac316 sequences from nt 6450 to 8158 (239/316SU) replicated even better in macrophages than the 239/316TM recombinant. These results indicate that amino acids in gpl20 contain major determinants of macrophage tropism. However, in repeated experiments, neither the 239/316SU nor the 239/316TM recombinant replicated as well as the full 239/316ENV recombinant (Fig. 3B) . These results indicate that the determinants of macrophage tropism are complex and distributed across the full length of this region.
Amino acid changes responsible for macrophage tropism.
Seven clones from the SphI (nt 6450) to SstI (nt 9230) sites were derived from SIVmac316-infected macrophages and sequenced (Fig. 4) . Only two of these, 316-3 and 316-6, yielded infectious virus when recombined into the SIVmac239 genome. This result is consistent with the results of the DNA sequence analysis, which revealed that clones 316-1, 316-2, 316-4, 316-5, and 316-7 had obvious defects in env that would preclude replication competence (Fig. 4) . Clones 316-3 and 316-6 had the same sequence (Fig. 4) . Measurement of recombinant 239/316ENV replication, shown in Fig. 3 , was done with the 316-3 clone. The DNA sequence of 316-3 revealed only 13 nt differences within nt 6450 to 9230 compared with the parental SIVmac239. Three of these changes, at nt 7890, 8268, and 8547, were silent in that they did not change the encoded amino acid in any of the known reading frames. One of the changes, at nt 9210, did not alter the encoded amino acid in the env reading frame (Arg), but it did change a Gly to Glu in the overlapping nef reading frame (Fig. 5) . Mutations in nef, including a 182-bp deletion, were recently shown not to alter replication of the 316 clone appreciably in rhesus monkey alveolar macrophages (15), so this mutation was not considered further. The remaining nine mutations changed the encoded amino acid within env (Fig. 4 and 5 ). Of these nine changes, six were in SU (gp120) and three were in TM (gp4l).
Individual site-specific mutations were then made in an attempt to define specific amino acid changes responsible for or contributing to the macrophage tropism. Nine individual forward mutants (239-316) with a single-amino-acid substitution were constructed, and nine individual backward mutants (316--239) were also made with a single-amino-acid substitution (Fig. 5) . These eighteen site-specific mutants were then tested in repeated experiments for their replicative capacity in macrophages relative to that of the parental strain (Table 1 Two of the nucleotide changes in the TM portion of the SIVmac316 env gene also resulted in amino acid changes in the second exon of tat and/or rev (Fig. 5) . The (Table 1) . We also have evidence that the enhancing effect of the G to T change at nt 8902 (Fig. 6A, 767E --**) is due to truncation of the transmembrane protein and not to an effect on tat or rev. A similar premature truncation was created slightly upstream in SIVmac239 by changing a C to T at nt 8803. This changed a Gln at env amino acid 734 to a stop without affecting tat or rev. This virus replicated better than the parental SIVmac239 in macrophages and replicated very similar to the 767E--** mutant shown in Fig. 6A (data not shown) . These results indicate that the enhanced replication of 767E--+* in macrophages is likely due to the truncation of the transmembrane protein and not to the changes in tat or rev.
Amino acid changes in env of another macrophagetropic virus derived from SlVmac239. Rhesus monkey 132-87 died 180 days after SIVmac239 infection with disseminated cytomegalovirus infection, SIV-related granulomatous pneumonia, and glomerulonephropathy. SIV recovered from peripheral blood near the time of death of this animal also replicated well in primary rhesus monkey alveolar macrophage cultures, similar to SIVmac3l6 (6) . Five clones spanning env were obtained from this independent macrophagetropic variant and sequenced (Fig. 4) . 
DISCUSSION
Not all of the animals that die from SIVmac239 infection show the emergence of macrophagetropic variants. In fact, three of the five animals that we have studied in detail showed no evidence of macrophage-tropic variants in the peripheral blood near the time of death, showed little or no evidence of infected macrophages in tissues taken at the time of death, and showed no histologic lesions that are associated with SIV or HIV infection of macrophages (6) . Granulomatous encephalitis and/or giant cell pneumonia were specifically associated with the emergence of macrophagetropic variants in rhesus monkeys 316-85 and 132-87. Thus, the appearance of macrophagetropic variants appears to influence the disease course and the specific pathologic manifestations that are observed.
We defined three amino acid changes in SU (67V-*M, 176K-*E, and 382G-*R) and two amino acid changes in TM (573K--T and 767E-*stop codon) that contribute to the macrophage tropism of SIVmac316 in vitro. Although the premature truncation of the transmembrane protein in cloned 316 contributes to its ability to replicate in macrophages in cell culture, we believe that this effect is peculiar to the in vitro-cultivated virus and that it is not likely to be physiologically relevant. This belief is based on the sequence of env clones obtained directly from tissues that were rich in infected macrophages from monkey 316-85. Although the 67V-M, 176K--E, 382G-*R, and 573K-*T sequence changes that contribute to the macrophage tropism of SIVmac316 were independently observed in these tissues, premature truncation of the cytoplasmic domain of TM was not observed in these clones direct from tissues (19a) . Previous studies have shown that truncation of the TM protein can enhance replication of SIVmac in some human cells and that such truncated forms can in fact be preferentially selected in these cells (20) . However, the SIVmac316 strain used for these studies had never been passaged in human cells or cell lines. Thus, we have defined four amino acids in env (67M, 176E, 382R, and 573T) that play a major, physiologically relevant role in determining whether SIVmac316 will replicate in macrophages (Fig. 4) .
Changes in addition to these four may also influence the ability to replicate in macrophages in a physiologically relevant fashion, but it may be difficult to demonstrate this unambiguously. This is true not only for other amino acid changes within env but also for regions outside of env. For example, inclusion of SIVmac316 sequences left of the SphI site at nt 6450 usually resulted in slightly better replication in macrophages than when left-half sequences of SIVmac239 were used. In any event, major sequence determinants that allow vigorous 'SIVmac replication in macrophages and lymphocytes, as opposed to lymphocytes only, reside in env.
Furthermore, these determinants are complex in that four or more sequence changes contribute to the maximal effect and these sequences are located in both gpl20 and gp41.
Our results are similar to recent reports for HIV-1 (13, 27, 33) in that major determinants of macrophage tropism were found to map to env. They differ, however, in that changes in the SIVmac region corresponding to V3 of HIV-1 were not associated with macrophage tropism (Fig. 4) . In one study, the V3 loop sequences of a macrophagetropic HIV-1 were able to impart maximal levels of macrophage replication to a non-macrophagetropic variant (13) . Determinants of HIV-1 macrophage tropism in other studies were also located in the vicinity of V3 (27, 33) . However, these results do not necessarily mean that the determinants of HIV-1 and SIVmac macrophage tropism are fundamentally different. Several studies have shown that regions in HIV-1 env outside of V3 can also contribute in a major way to HIV-1 macrophage tropism. For example, a 480-bp exchange spanning V3 in the reports of O'Brien et al. (27) and Shioda et al. (33) imparted only 5 to 10% of the full replicative capacity for macrophages. This suggests that the determinants of HIV-1 macrophage tropism can also be complex and that individual results will depend on the particular pair of clones being used to make the recombinants. Furthermore, it is possible that sequences in SIVmac corresponding to V3 in HIV-1 may be important for determining macrophage tropism; V3-corresponding sequences in SIVmac239 may already be nearly optimal for virus replication in macrophages. In our current study, we have precisely defined specific amino acid changes outside of V3 that contribute to the ability of the virus to replicate in macrophages.
We do not know the mechanisms by which these few defined changes in env can result in such a dramatic difference in ability to replicate in macrophages. Based on previous work with HIV-1 (16), virus entry is one likely possibility, but t'his has not yet been demonstrated for our cloned viruses. This question is particularly intriguing because infection of lymphoid cells by SIVmac239 and recombinant 239/316ENV and infection of macrophages by recombinant 239/316ENV are significantly inhibited by OKT4A monoclonal antibodies (data not shown). If the difference is indeed at the level of virus entry into macrophages, the closely matched clones described in this report will be useful in defining some of the key post-CD4-binding steps that have so far eluded investigators. The advantages of the system described in this report are the minimum number of defined sequence changes in env in the matched clones and the enormous difference (more than 100-fold) in ability to replicate in cultured macrophages. The evolution of macrophagetropic variants in rhesus monkeys infected with cloned SIVmac239 was associated with the presence of specific pathologic lesions in which infected macrophages are the primary cells. These include granulomatous encephalitis and giant cell pneumonia. In this sense, the presence of macrophagetropic virus appears to influence the disease course and the specific pathologic manifestations that are observed. The importance of macrophage infection for other aspects of AIDS, including viral persistence, the chronic nature of the disease, and immune deficiency, remains to be elucidated.
